Trial Profile
Phase II trial of YHI-1003 monotherapy in patients with advanced or relapsed gynecologic cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Cervical cancer; Endometrial cancer; Ovarian cancer
- Focus Therapeutic Use
- Sponsors Yakult Honsha
- 07 Jun 2016 New trial record